1. Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy. Issue 3 (1st April 2006) Authors: Kastritis, E.; Efstathiou, E.; Gika, D.; Bozas, G.; Koutsoukou, V.; Papadimitriou, C.; Pissakas, G.; Dimopoulos, M. A.; Bamias, A. Journal: International journal of gynecological cancer Issue: Volume 16:Issue 3(2006) Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Colon Adenoma Implicating Myasthenia Gravis: A Case Report of a Patient with Postcolectomy Complications. (17th August 2016) Authors: Papachatzakis, Y.; Tseliou, E.; Tatouli, I.; Dialoupi, I.; Michas, F.; Papadopoulou, E.; Kousouris, D.; Kontogiannis, S.; Dimopoulos, M. A. Other Names: Fee Dominic B. Academic Editor. Journal: Case reports in neurological medicine Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience. Issue 5 (1st September 2007) Authors: Pectasides, D.; Fountzilas, G.; Aravantinos, G.; Bamias, A.; Kalofonos, H. P.; Skarlos, D.; Briasoulis, E.; Konstantara, A.; Economopoulos, Th.; Dimopoulos, M. A. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 5(2007) Page Start: 1003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1507: CLINICAL PROFILE OF COVID-19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS-COV-2 IN ADULT PATIENTS WITH TRANSFUSION-DEPENDENT THALASSAEMIA-THE EXPERIENCE OF A GREEK CENTER. (23rd June 2022) Authors: Delaporta, P.; Terpos, E.; Solomou, E. E.; Gumeni, S.; Chatzielefteriou, M.-I.; Toutoudaki, K.; Kyriakopoulou, D.; Ioakeimidou, N.; Ntanasis-Stathopoulos, I.; Papassotiriou, I.; Trougakos, I. P.; Dimopoulos, M. A.; Kattamis, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE. (23rd June 2022) Authors: Jaccard, A.; Bridoux, F.; Roeloffzen, W.; Minnema, M. C.; Bergantim, R.; Hájek, R.; João, C.; Cibeira, M. T.; Palladini, G.; Schönland, S.; Merlini, G.; Milani, P.; Dimopoulos, M. A.; Ravichandran, S.; Hegenbart, U.; Agis, H.; Gros, B.; Asra, A.; Dergarabetian, E.; Magarotto, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK. (23rd June 2022) Authors: Kastritis, E.; Palladini, G.; Dimopoulos, M. A.; Jaccard, A.; Merlini, G.; Theodorakakou, F.; Fotiou, D.; Minnema, M. C.; Wechalekar, A.; Gkolfinopoulos, S.; Manousou, K.; Sonneveld, P.; Schönland, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK. (23rd June 2022) Authors: Kastritis, E.; Minnema, M. C.; Dimopoulos, M. A.; Merlini, G.; Theodorakakou, F.; Fotiou, D.; Huart, A.; Belhadj, K.; Gkolfinopoulos, S.; Manousou, K.; Sonneveld, P.; Palladini, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY. (23rd June 2022) Authors: Spencer, A.; Moreau, P.; Mateos, M.-V.; Goldschmidt, H.; Suzuki, K.; Levin, M.-D.; Sonneveld, P.; Yoon, S.-S.; Usmani, S. Z.; Weisel, K.; Reece, D.; Ahmadi, T.; Pei, H.; Garvin Mayo, W.; Gai, X.; Carey, J.; Carson, R.; Dimopoulos, M. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA. (23rd June 2022) Authors: Munshi, N.; Spencer, A.; Raab, M. S.; Masood, A.; Martinez-Prieto, M.; Chu, J.; Iida, S.; Lonial, S.; Dimopoulos, M. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA. (23rd June 2022) Authors: Delimpasi, S.; Quach, H.; Cavo, M.; Ho, P. J.; Lee, C. H.-S.; Santoro, A.; Schots, R.; Vlummens, P.; Yoon, D. H.; Yoon, S.-S.; Santos, C. D.; Samineni, D.; Huang, J.; Wehrman, K.; Patil, U.; Sheikh, S.; Dimopoulos, M. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗